Advertisement

Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation

Published:October 27, 2022DOI:https://doi.org/10.1016/j.jgo.2022.10.012

      Abstract

      Introduction

      Exploring symptom experiences of older men during metastatic prostate cancer treatment can help clinicians identify unmet supportive care needs that, if addressed, could improve toxicity management and enhance patient wellbeing. Previous qualitative studies of older adults with advanced prostate cancer have focused on the psychological experience rather than the overall symptom experience. Therefore, the objective of this study was to understand the lived experience of symptoms and supportive care needs in older men undergoing treatment for metastatic prostate cancer.

      Materials and Methods

      Semi-structured interviews were conducted with older adults (aged 65+) who completed their first cycle of chemotherapy, androgen-axis targeted therapies, or radium-223 for metastatic castrate-resistant and sensitive prostate cancer at the Princess Margaret Cancer Centre, Toronto, Canada. Six coders worked in pairs to review interview transcripts and conduct a thematic analysis. A consensus was reached through team discussions. Topics of interest included symptom experiences, the impact of symptoms on daily life, symptom management strategies, and suggestions for external support.

      Results

      Thirty-six interviews were conducted with older adults (mean age: 76 years, 92% with metastatic castrate-resistant prostate cancer) who started chemotherapy (n = 11), androgen-axis targeted therapies (n = 19), or radium-223 (n = 6). The most common treatment-specific symptoms included: fatigue, pain, sleep disturbances, mood disturbances, and gastrointestinal symptoms. Four themes on the impact of symptoms on daily life emerged: resting more than usual, changes in mobility, changes in maintaining activities of daily living, and not feeling up to most things. It is important to note that participants who underwent chemotherapy have previously completed other lines of treatment and had more advanced disease, possibly contributing to higher prevalence of symptoms and greater impact on daily life. Four themes on symptom management strategies emerged: positive support systems, seeking help, interventions by healthcare providers, and self-management strategies. Suggestions for external support included building social support networks, improving health literacy, improving continuity of care, receiving support from healthcare providers, engaging in health-seeking behaviours, and addressing unmet supportive care needs.

      Discussion

      Exploring symptom experiences of older men with metastatic prostate cancer provides valuable insights for developing supportive care programs and improving patient care.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H.
        • Ferlay J.
        • Siegel R.L.
        • Laversanne M.
        • Soerjomataram I.
        • Jemal A.
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2021; : 71https://doi.org/10.3322/caac.21660
        • Canadian Cancer Statistics Advisory Committee
        Canadian Cancer Statistics.
        2021. 2021
        • Droz J.P.
        • Aapro M.
        • Balducci L.
        • Boyle H.
        • van den Broeck T.
        • Cathcart P.
        • et al.
        Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.
        Lancet Oncol. 2014; : 15https://doi.org/10.1016/S1470-2045(14)70018-X
        • Canadian Cancer Data Tool (CCDT)
        Health Infobase - Public Health Agency of Canada.
        (accessed February 24, 2022)
        • Ferlay J.
        • Ervik M.
        • Lam F.
        • Colombet M.
        • Mery L.
        • Piñeros M.
        • et al.
        Global cancer observatory: Cancer today.
        International Agency for Research on Cancer, Lyon, France2020 (accessed March 9, 2022)
        • Chi K.
        • Hotte S.J.
        • Joshua A.M.
        • North S.
        • Wyatt A.W.
        • Collins L.L.
        • et al.
        Treatment of mCRPC in the AR-axis-targeted therapy-resistant state.
        Ann Oncol. 2015; : 26https://doi.org/10.1093/annonc/mdv267
        • Sawhney R.
        • Sehl M.
        • Naeim A.
        Physiologic aspects of aging: impact on cancer management and decision making, part I.
        Cancer J. 2005; : 11https://doi.org/10.1097/00130404-200511000-00004
        • Sehl M.
        • Sawhney R.
        • Naeim A.
        Physiologic aspects of aging: impact on cancer management and decision making, part II.
        Cancer J. 2005; : 11https://doi.org/10.1097/00130404-200511000-00005
        • Mohler J.L.
        • Antonarakis E.S.
        • Armstrong A.J.
        • D’Amico A.V.
        • Davis B.J.
        • Dorff T.
        • et al.
        Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology.
        J Natl Compr Canc Netw. 2019; : 17https://doi.org/10.6004/jnccn.2019.0023
        • Parker C.
        • Nilsson S.
        • Heinrich D.
        • Helle S.I.
        • O’Sullivan J.M.
        • Fosså S.D.
        • et al.
        Alpha emitter Radium-223 and survival in metastatic prostate Cancer.
        New England Journal of Medicine. 2013; : 369https://doi.org/10.1056/nejmoa1213755
        • Teo M.Y.
        • Rathkopf D.E.
        • Kantoff P.
        Treatment of advanced prostate cancer.
        Annu Rev Med. 2019; : 70https://doi.org/10.1146/annurev-med-051517-011947
        • Kobayashi K.
        • Okuno N.
        • Arai G.
        • Nakatsu H.
        • Maniwa A.
        • Kamiya N.
        • et al.
        Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.
        Jpn J Clin Oncol. 2021; : 51https://doi.org/10.1093/jjco/hyaa225
        • Wilson J.M.
        • Parker C.
        The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer.
        Expert Rev Anticancer Ther. 2016; 16https://doi.org/10.1080/14737140.2016.1222273
        • Shore N.D.
        • Chowdhury S.
        • Villers A.
        • Klotz L.
        • Robert Siemens D.
        • Phung D.
        • et al.
        Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.
        Lancet Oncol. 2016; : 17https://doi.org/10.1016/S1470-2045(15)00518-5
        • de Sousa A.
        • Sonavane S.
        • Mehta J.
        Psychological aspects of prostate cancer: a clinical review.
        Prostate Cancer Prostatic Dis. 2012; : 15https://doi.org/10.1038/pcan.2011.66
        • Sharpley C.F.
        • Christie D.R.H.
        • Bitsika V.
        Depression and prostate cancer: implications for urologists and oncologists.
        Nat Rev Urol. 2020; : 17https://doi.org/10.1038/s41585-020-0354-4
        • Watts S.
        • Leydon G.
        • Birch B.
        • Prescott P.
        • Lai L.
        • Eardley S.
        • et al.
        Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates.
        BMJ Open. 2014; : 4https://doi.org/10.1136/bmjopen-2013-003901
        • Fitch M.I.
        • Coronado A.C.
        • Schippke J.C.
        • Chadder J.
        • Green E.
        Exploring the perspectives of patients about their care experience: identifying what patients perceive are important qualities in cancer care.
        Support Care Cancer. 2020; : 28https://doi.org/10.1007/s00520-019-05057-9
        • Fitch M.I.
        • Longo C.J.
        Emerging understanding about the impact of financial toxicity related to Cancer: Canadian perspectives.
        Semin Oncol Nurs. 2021; : 37https://doi.org/10.1016/j.soncn.2021.151174
        • Definition of supportive care - NCI Dictionary of Cancer Terms - National Cancer Institute
        (accessed February 24, 2022)
        • Basch E.
        • Deal A.M.
        • Dueck A.C.
        • Scher H.I.
        • Kris M.G.
        • Hudis C.
        • et al.
        Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.
        JAMA. 2017; : 318https://doi.org/10.1001/jama.2017.7156
        • Basch E.
        • Deal A.M.
        • Kris M.G.
        • Scher H.I.
        • Hudis C.A.
        • Sabbatini P.
        • et al.
        Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial.
        J Clin Oncol. 2016; : 34https://doi.org/10.1200/JCO.2015.63.0830
        • Bridge E.
        • Gotlib Conn L.
        • Dhanju S.
        • Singh S.
        • Moody L.
        The patient experience of ambulatory cancer treatment: a descriptive study.
        Current Oncology. 2019; : 26https://doi.org/10.3747/co.26.4191
        • Magalhães B.
        • Carla F.
        • Lima L.
        • Martinez-Galiano J.M.
        • Célia S.
        Cancer patients’ experiences on self-management of chemotherapy treatment-related symptoms: a systematic review and thematic synthesis.
        Eur J Oncol Nurs. 2020; : 49https://doi.org/10.1016/j.ejon.2020.101837
        • Mccaffery K.
        • Nickel B.
        • Pickles K.
        • Moynihan R.
        • Kramer B.
        • Barratt A.
        • et al.
        Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.
        BMJ Open. 2019; : 9https://doi.org/10.1136/BMJOPEN-2018-026960
        • Hagen B.
        • Grant-Kalischuk R.
        • Sanders J.
        Disappearing floors and second chances: Men’s journeys of prostate cancer.
        Int J Mens Health. 2007; 6: 201-223https://doi.org/10.3149/JMH.0603.201
        • Buote R.
        • Cameron E.
        • Collins R.
        • McGowan E.
        Understanding Men’s experiences with prostate Cancer stigma: a qualitative study.
        Oncol Nurs Forum. 2020; 47: 577-585https://doi.org/10.1188/20.ONF.577-585
        • Davis J.D.
        Coping with prostate cancer: The lived experience.
        2002
        • Sandelowski M.
        What’s in a name? Qualitative description revisited.
        Res Nurs Health. 2010; : 33https://doi.org/10.1002/nur.20362
        • Sandelowski M.
        Whatever happened to qualitative description?.
        Res Nurs Health. 2000; : 23https://doi.org/10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g
        • Parthipan M.
        • Feng G.
        • Breunis H.
        • Emmenegger U.
        • Hansen A.
        • Finelli A.
        • et al.
        Patterns of treatment toxicity in frail older men with metastatic prostate cancer.
        J Geriatr Oncol. 2021; 12: S20-S21https://doi.org/10.1016/S1879-4068(21)00365-9
        • Parthipan M.
        • Toledano N.
        • Feng G.
        • Breunis H.
        • Emmenegger U.
        • Hansen A.
        • et al.
        Symptom experiences of older adults undergoing treatment for metastatic castrate-resistant prostate cancer.
        J Geriatr Oncol. 2021; 12: S30https://doi.org/10.1016/S1879-4068(21)00383-0
        • Feng G.
        • Parthipan M.
        • Breunis H.
        • Emmenegger U.
        • Hansen A.
        • Finelli A.
        • et al.
        Psychological distress in older adults during treatment for advanced prostate Cancer.
        J Geriatr Oncol. 2021; 12: S28-S29https://doi.org/10.1016/S1879-4068(21)00381-7
        • Hennink M.M.
        • Kaiser B.N.
        • Marconi V.C.
        Code saturation versus meaning saturation: how many interviews are enough?.
        Qual Health Res. 2017; 27: 591-608https://doi.org/10.1177/1049732316665344
        • Saliba D.
        • Elliott M.
        • Rubenstein L.Z.
        • Solomon D.H.
        • Young R.T.
        • Kamberg C.J.
        • et al.
        The vulnerable elders survey: a tool for identifying vulnerable older people in the community.
        J Am Geriatr Soc. 2001; : 49https://doi.org/10.1046/j.1532-5415.2001.49281.x
        • Fillenbaum G.G.
        • Smyer M.A.
        The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire.
        Journals of Gerontology. 1981; : 36https://doi.org/10.1093/geronj/36.4.428
        • Oken M.M.
        • Creech R.H.
        • Davis T.E.
        Toxicology and response criteria of the eastern cooperative oncology group.
        American Journal of Clinical Oncology: Cancer Clinical Trials. 1982; : 5https://doi.org/10.1097/00000421-198212000-00014
        • Miller M.D.
        • Paradis C.F.
        • Houck P.R.
        • Mazumdar S.
        • Stack J.A.
        • Rifai A.H.
        • et al.
        Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale.
        Psychiatry Res. 1992; : 41https://doi.org/10.1016/0165-1781(92)90005-N
        • Sattar S.
        • Alibhai S.M.H.
        • Fitch M.
        • Krzyzanowska M.
        • Leighl N.
        • Puts M.T.E.
        Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: a qualitative study.
        J Geriatr Oncol. 2018; : 9https://doi.org/10.1016/j.jgo.2017.07.013
        • Collaço N.
        • Rivas C.
        • Matheson L.
        • Nayoan J.
        • Wagland R.
        • Alexis O.
        • et al.
        Prostate cancer and the impact on couples: a qualitative metasynthesis.
        Support Care Cancer. 2018; : 26https://doi.org/10.1007/s00520-018-4134-0
        • Sibeoni J.
        • Picard C.
        • Orri M.
        • Labey M.
        • Bousquet G.
        • Verneuil L.
        • et al.
        Patients’ quality of life during active cancer treatment: a qualitative study.
        BMC Cancer. 2018; : 18https://doi.org/10.1186/s12885-018-4868-6
        • Braun V.
        • Clarke V.
        Using thematic analysis in psychology.
        Qual Res Psychol. 2006; : 3https://doi.org/10.1191/1478088706qp063oa
        • Horgan A.M.
        • Seruga B.
        • Pond G.R.
        • Alibhai S.M.
        • Amir E.
        • de Wit R.
        • et al.
        Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.
        J Geriatr Oncol. 2014; : 5https://doi.org/10.1016/j.jgo.2013.12.001
        • Alibhai S.M.H.
        • Breunis H.
        • Hansen A.R.
        • Gregg R.
        • Warde P.
        • Timilshina N.
        • et al.
        Examining the ability of the Cancer and aging research group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor–targeted therapy for metastatic castration-resistant prostate cancer.
        Cancer. 2021; : 127https://doi.org/10.1002/cncr.33523
        • Ged Y.
        • Horgan A.M.
        Management of castrate-resistant prostate cancer in older men.
        J Geriatr Oncol. 2016; : 7https://doi.org/10.1016/j.jgo.2016.01.001
        • Rocque G.B.
        • Williams G.R.
        Bridging the data-free zone: decision making for older adults with cancer.
        J Clin Oncol. 2019; : 37https://doi.org/10.1200/JCO.19.02588
        • Rostoft S.
        • van den Bos F.
        • Pedersen R.
        • Hamaker M.E.
        Shared decision-making in older patients with cancer - what does the patient want? J Geriatr.
        Oncol. 2021; : 12https://doi.org/10.1016/j.jgo.2020.08.001
        • Soeyonggo T.
        • Warde P.
        • Fleshner N.
        • Timilshina N.
        • Alibhai S.M.H.
        Information needs of men on androgen deprivation therapy.
        BJU Int. 2012; : 109https://doi.org/10.1111/j.1464-410X.2011.10475.x
        • Rutten L.J.F.
        • Arora N.K.
        • Bakos A.D.
        • Aziz N.
        • Rowland J.
        Information needs and sources of information among cancer patients: a systematic review of research (1980-2003).
        Patient Educ Couns. 2005; : 57https://doi.org/10.1016/j.pec.2004.06.006
        • Kadambi S.
        • Soto-Perez-de-Celis E.
        • Garg T.
        • Loh K.P.
        • Krok-Schoen J.L.
        • Battisti N.M.L.
        • et al.
        Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper.
        J Geriatr Oncol. 2020; : 11https://doi.org/10.1016/j.jgo.2019.09.005
        • White L.L.
        • Cohen M.Z.
        • Berger A.M.
        • Kupzyk K.A.
        • Bierman P.J.
        Self-efficacy for management of symptoms and symptom distress in adults with cancer: an integrative review.
        Oncol Nurs Forum. 2019; : 46https://doi.org/10.1188/19.ONF.113-128
        • Haase K.R.
        • Sattar S.
        • Hall S.
        • McLean B.
        • Wills A.
        • Gray M.
        • et al.
        Systematic review of self-management interventions for older adults with cancer.
        Psychooncology. 2021; : 30https://doi.org/10.1002/pon.5649
        • Rowntree R.A.
        • Hosseinzadeh H.
        Lung Cancer and self-management interventions: a systematic review of randomised controlled trials.
        Int J Environ Res Public Health. 2022; : 19https://doi.org/10.3390/ijerph19010536
        • Soo W.-K.
        • King M.
        • Pope A.
        • Parente P.
        • Darzins P.
        • Davis I.D.
        Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy.
        38. 2020: 12011https://doi.org/10.1200/JCO.2020.38.15_SUPPL.12011
        • Li D.
        • Sun C.L.
        • Kim H.
        • Soto-Perez-De-Celis E.
        • Chung V.
        • Koczywas M.
        • et al.
        Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
        JAMA Oncol. 2021; 7: e214158https://doi.org/10.1001/JAMAONCOL.2021.4158
        • Mooney K.H.
        • Beck S.L.
        • Wong B.
        • Dunson W.
        • Wujcik D.
        • Whisenant M.
        • et al.
        Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT.
        Cancer Med. 2017; : 6https://doi.org/10.1002/cam4.1002
        • Maguire R.
        • McCann L.
        • Kotronoulas G.
        • Kearney N.
        • Ream E.
        • Armes J.
        • et al.
        Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). The.
        BMJ. 2021; : 374https://doi.org/10.1136/bmj.n1647
        • Xiong X.
        • Xu H.
        • Wang S.
        • Liao X.
        • Yi X.
        • Jin K.
        • et al.
        Association of Novel Androgen Receptor Axis-Targeted Therapies with Diarrhea in patients with prostate Cancer: a Bayesian network analysis.
        Front Med (Lausanne). 2022; 8800823https://doi.org/10.3389/FMED.2021.800823/FULL
        • Wang T.
        • Molassiotis A.
        • Chung B.P.M.
        • Tan J.Y.
        Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review.
        BMC Palliat Care. 2018; 17: 1-29https://doi.org/10.1186/S12904-018-0346-9